Industry-sponsored CME
Executive Summary
FDA Deputy Commissioner for Policy Michael Taylor met with Pharmaceutical Manufacturers Association officials on April 15 to review the agency's revised concept paper on industry-supported continuing medical education. PMA views the current draft as greatly improved over earlier drafts. FDA is doing its political spadework this time, carefully previewing its modified CME policy with interested parties, including HHS and the Office of Management and Budget, before it is issued....